The COVID-19 pandemic has had dramatic implications for workplaces across Canada. A new report, Impact of COVID-19 on Pensions and Benefits in Canada, examines the myriad effects of the pandemic… Read more >
July 16, 2020 Canada, Coronavirus (COVID-19), Defined Contribution (DC) Plans, Mental Health, Prescription Drugs 0 Read more >
As the coronavirus pandemic took hold, some organizations adopted safer-at-home work environments, while others were deemed essential and saw their work shift from routine tasks to risk-taking heroics. Others were forced… Read more >
May 13, 2020 Coronavirus (COVID-19), Employee Benefits, Health Care, Mental Health, Prescription Drugs 0 Read more >
The coronavirus is a challenge unlike any most employers have faced. The pandemic has brought major changes to the workplace, including shifts to employees’ health care and retirement benefits. A… Read more >
May 11, 2020 Coronavirus (COVID-19), Employee Benefits, Health Care, Prescription Drugs, Retirement 0 Read more >
Grown-ups. Kids. Fathers. Mothers. Sisters. Brothers. The statistics are grim—the United States and Canada are the top two nations in the world in per capita consumption of prescription opioids, with… Read more >
February 4, 2020 Canada, Employee Benefits, Health Care, Prescription Drugs, Wellness 0 Read more >
If you watch television at all, you probably have a pretty keen awareness that there are all kinds of new and amazing drugs on the market these days. Some cure… Read more >
December 12, 2019 Affordable Care Act (ACA), Employee Benefits, Health Care, Prescription Drugs 0 Read more >
Have you ever taken a medication that didn’t work or, worse, made you sicker? Maybe you had to throw away a bottle of pills and go back to your doctor… Read more >
June 20, 2019 Employee Benefits, Health Care, Prescription Drugs 0 Read more >
Benefits practitioners have grown accustomed to headlines addressing the escalating costs of prescription drugs. A recently released congressional report stated that the prices of commonly prescribed brand-name drugs have risen… Read more >
March 19, 2019 Employee Benefits, Health Care, Prescription Drugs 0 Read more >
The opioid crisis continues to sweep across the United States and Canada, and workplaces are feeling the impact. The recent International Foundation report, Mental Health and Substance Abuse Benefits: 2018… Read more >
February 5, 2019 Employee Benefits, Mental Health, Opioid Abuse, Prescription Drugs 0 Read more >
Benefits practitioners have grown accustomed to headlines addressing escalating prescription drug costs. A recently released congressional report stated that the prices of commonly prescribed brand-name drugs have risen at a… Read more >
October 15, 2018 Employee Benefits, Health Care, Prescription Drugs 0 Read more >
The opioid crisis has far-reaching impacts in both the United States and Canada, including the workforce. John S. Gaal, Ed.D., director of training for St. Louis-Kansas City Carpenters Regional Council,… Read more >
September 5, 2018 Employee Benefits, Health Care, Prescription Drugs 0 Read more >